Your browser doesn't support javascript.
loading
Addressing barriers to increased adoption of DPYD genotyping at a large multisite cancer center.
Morris, Sarah A; Moore, Donald C; Musselwhite, Laura W; Lopes, Karine Eboli; Hamilton, Alicia; Steuerwald, Nury; Hanson, Sarah L; Larck, Chris; Swift, Kristen; Smith, Mathew; Kadakia, Kunal C; Chai, Seungjean; Hwang, Jimmy J; Patel, Jai N.
Afiliação
  • Morris SA; Department of Cancer Pharmacology & Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Moore DC; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Musselwhite LW; Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Lopes KE; Department of Cancer Pharmacology & Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Hamilton A; Molecular Biology and Genomics Core Facility, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Steuerwald N; Molecular Biology and Genomics Core Facility, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Hanson SL; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Larck C; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Swift K; Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Smith M; Molecular Biology and Genomics Core Facility, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Kadakia KC; Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Chai S; Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Hwang JJ; Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Patel JN; Department of Cancer Pharmacology & Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Am J Health Syst Pharm ; 80(19): 1342-1349, 2023 09 22.
Article em En | MEDLINE | ID: mdl-37235983

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Di-Hidrouracila Desidrogenase (NADP) / Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Am J Health Syst Pharm Assunto da revista: FARMACIA / HOSPITAIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Di-Hidrouracila Desidrogenase (NADP) / Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Am J Health Syst Pharm Assunto da revista: FARMACIA / HOSPITAIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido